Clinical Trial Detail

NCT ID NCT03862157
Title Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

chronic myelomonocytic leukemia

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic neutrophilic leukemia

acute myeloid leukemia

essential thrombocythemia

chronic eosinophilic leukemia

myeloproliferative neoplasm

polycythemia vera

myeloid neoplasm

Therapies

Azacitidine + MLN4924 + Venetoclax

Age Groups: adult senior

Additional content available in CKB BOOST